NFL Biosciences SAS Cash Flow Conversion Efficiency

Latest as of June 2023: 0.030x

NFL Biosciences SAS cash flow conversion efficiency. Based on the latest financial reports, NFL Biosciences SAS (ALNFL) has a cash flow conversion efficiency ratio of 0.030x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€57.51K ≈ $67.24K USD) by net assets (€1.91 Million ≈ $2.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of NFL Biosciences SAS (2020–2022)

Cash flow conversion efficiency of NFL Biosciences SAS from 2020 to 2022. This chart illustrates how NFL Biosciences SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest NFL Biosciences SAS stock price today for real-time trading data and today's change.

NFL Biosciences SAS Cash Flow Conversion Ratio Explained

NFL Biosciences SAS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

NFL Biosciences SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NFL Biosciences SAS ranked by their cash flow conversion efficiency. Also see ALNFL company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Combigene AB ST:COMBI	-0.087x
VIA OPTRONICS AG SP.ADS/1 F:5UU1	N/A
SOLAI Limited NYSE:SLAI	-0.355x
ASN Broker Public Company Limited BK:ASN	0.027x
Automobile &Pc KO:015260	0.067x
KST Beteiligungs AG F:KSW	N/A
Sonoma Pharmaceuticals Inc NASDAQ:SNOA	-0.098x
Teamo Productions HQ Limited NSE:TPHQ	0.150x

Annual Cash Flow Conversion Efficiency for NFL Biosciences SAS (2020–2022)

The table below shows the annual cash flow conversion efficiency of NFL Biosciences SAS from 2020 to 2022. Review ALNFL free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	€844.00K ≈ $986.72K	€104.89K ≈ $122.63K	0.124x	+369.60%
2021-12-31	€3.29 Million ≈ $3.84 Million	€87.00K ≈ $101.71K	0.026x	-95.27%
2020-12-31	€150.03K ≈ $175.39K	€83.91K ≈ $98.10K	0.559x	--

About NFL Biosciences SAS

PA:ALNFL France Biotechnology

Market Cap

$5.23 Million

€4.47 Million EUR

Market Cap Rank

#28502 Global

#528 in France

Share Price

€0.35

Change (1 day)

-5.87%

52-Week Range

€0.34 - €1.65

All Time High

€4.75